Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

June 23, 2020

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.
Click here to find out more about Abcam’s SimpleStep ELISA® for blood biomarkers.

Protease and phosphatase inhibitor cocktails

Protease and phosphatase inhibitor cocktails

Protease and phosphatase inhibitors are essential components of most cell lysis and protein isolation procedures. Abcam has developed a range of convenient and easy to use protease and phosphatase inhibitor cocktails, which are suitable for a variety of applications.

April 30, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us